Article
Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1.
Proceedings of the National Academy of Sciences of the United States of America - 14 Mar 1995
McGlynn K A, Rosvold E A, Lustbader E D, Hu Y, Clapper M L, Zhou T, Wild C P, Xia X L, Baffoe-Bonnie A, Ofori-Adjei D
Abstract excerpt
Aflatoxin B1 (AFB1) has been postulated to be a hepatocarcinogen in humans, possibly by causing p53 mutations at codon 249. AFB1 is metabolized via the phase I and II detoxification pathways; hence, genetic variation at those loci may predict susceptibility to the effects of AFB1. To test this hypothesis, genetic variation in two AFB1 detoxification genes, epoxide hydrolase (EPHX) and glutathione S-transferase M1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
